CSIMarket
 


Neurotrope inc   (NTRP)
Other Ticker:  
 
 

NTRP's Operating Income Growth by Quarter and Year

Neurotrope Inc 's Operating Income results by quarter and year




NTRP Operating Income (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - -2.69 -3.78 -4.33
III Quarter September -2.58 -3.91 -3.20 -2.32
II Quarter June -3.01 -4.11 -2.15 -2.96
I Quarter March -2.61 -4.80 -2.01 -3.09
FY   -8.20 -15.51 -11.14 -12.70



NTRP Operating Income third quarter 2020 Y/Y Growth Comment
Neurotrope inc in the third quarter 2020 recorded Operating Loss of $ -2.58 millions.

According to the results reported in the third quarter 2020, Neurotrope Inc achieved the best Operating Income growth in Major Pharmaceutical Preparations industry. While Neurotrope Inc ' s Operating Income no change of % ranks overall at the positon no. in the third quarter 2020.

Explain Operating Income growth


NTRP Operating Income ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Neurotrope Inc 's third quarter 2020 Operating Income $ -2.58 millions NTRP's Income Statement
Neurotrope Inc 's third quarter 2019 Operating Income $ -3.91 millions Quarterly NTRP's Income Statement
New: More NTRP's historic Operating Income Growth >>


NTRP Operating Income (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Neurotrope Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


NTRP's III. Quarter Q/Q Operating Income Comment
Despite the fact, that Neurotrope inc in the III. Quarter 2020 revealed Operating Loss of $ -2.58 millions, some analyst point out, that this show recovery in contrast to the -3.01 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Neurotrope inc achieved highest sequential Operating Income growth. While Neurotrope Inc 's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


NTRP's III. Quarter Q/Q Operating Income Comment
Although Neurotrope inc in the III. Quarter 2020 admitted Operating Loss of $ -2.58 millions, management point out, that those numbers are recovery compare to the -3.01 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Neurotrope inc achieved highest sequential Operating Income growth. While Neurotrope Inc 's Operating Income growth quarter on quarter, overall rank is .


Neurotrope Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
Cumulative Operating Income 12 Months Ending $ -10.88 $ -12.22 $ -13.33 $ -15.51 $ -16.60
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment


Neurotrope inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment


Neurotrope inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Major Pharmaceutical Preparations Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
NTRP's Operating Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for NTRP's Competitors
Operating Income Growth for Neurotrope Inc 's Suppliers
Operating Income Growth for NTRP's Customers

You may also want to know
NTRP's Annual Growth Rates NTRP's Profitability Ratios NTRP's Asset Turnover Ratio NTRP's Dividend Growth
NTRP's Roe NTRP's Valuation Ratios NTRP's Financial Strength Ratios NTRP's Dividend Payout Ratio
NTRP's Roa NTRP's Inventory Turnover Ratio NTRP's Growth Rates NTRP's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Sep 30 2020 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Sep 30 2020
Amgen Inc -0.93%$ -0.929 millions
Tenax Therapeutics Inc -1.56%$ -1.561 millions
U s Neurosurgical Holdings Inc -2.74%$ -2.740 millions
Johnson and Johnson-3.21%$ -3.213 millions
3m Company-5.07%$ -5.072 millions
Hca Healthcare Inc -5.99%$ -5.991 millions
Baxter International Inc -6.56%$ -6.561 millions
Bruker Corporation-7.52%$ -7.517 millions
Tenet Healthcare Corp-7.82%$ -7.823 millions
Iqvia Holdings Inc -8.33%$ -8.333 millions
Acadia Healthcare Company Inc -9.75%$ -9.752 millions
Eli Lilly And Company-10.65%$ -10.652 millions
Biospecifics Technologies Corp-11.05%$ -11.051 millions
Nuvasive Inc-11.35%$ -11.346 millions
Emergent Biosolutions Inc -13.30%$ -13.296 millions
China Health Industries Holdings Inc -15.09%$ -15.091 millions
Catalyst Pharmaceuticals Inc -15.47%$ -15.467 millions
Utah Medical Products Inc-17.94%$ -17.936 millions
Carlisle Companies Incorporated-18.48%$ -18.482 millions
Fonar Corporation-20.10%$ -20.098 millions
Heartbeam Inc -20.74%$ -20.741 millions
Icu Medical Inc-22.40%$ -22.399 millions
Bristol myers Squibb Company-23.75%$ -23.750 millions
Hanger inc.-24.87%$ -24.869 millions
Corcept Therapeutics Inc-25.10%$ -25.103 millions
Dentsply Sirona Inc -25.39%$ -25.388 millions
Intuitive Surgical Inc -26.06%$ -26.060 millions
Atrion Corporation-27.44%$ -27.435 millions
Vanda Pharmaceuticals Inc -28.04%$ -28.042 millions
Hill rom Holdings Inc -29.65%$ -29.649 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com